Wuxi Boton Technology Co., Ltd. (300031.SZ) Bundle
Investors watching Wuxi Boton Technology Co., Ltd. will want to dig into the numbers: Q3 2025 revenue reached 849.84 million CNY (up 16.06% QoQ) against a trailing twelve months revenue of 3.31 billion CNY (down 10.15% YoY) and 2024 annual revenue of 3.30 billion CNY (‑9.67% YoY); profitability shows a TTM net income of 158.95 million CNY with a 5.55% profit margin and operating margin of 7.57%, while returns sit at ROA 2.46% and ROE 4.96% and EPS at 0.43 CNY, even as quarterly earnings growth is down 36.50% YoY; market metrics include a trailing P/E of 57.47, P/S 2.84, P/B 2.65, market cap ~9.80 billion CNY and recent share price levels (22.26 CNY on Dec 9, 2025; 23.41 CNY on Nov 4, 2025), supported by aggressive liquidity with TTM operating cash flow of 3.03 billion CNY, 4.88 billion CNY in dividends paid in 2025, and 2.0 billion CNY of A‑shares repurchased and cancelled-yet risks such as a 10.15% YoY revenue decline, -36.50% quarterly earnings growth, a controlling shareholder's planned up-to-2.00% stake reduction, and an enterprise/EBITDA of 32.79 contrast with analyst forecasts of 27.8% annual EPS growth and 14.9% revenue CAGR, so read on for a chapter‑by‑chapter breakdown of revenue, profitability, balance‑sheet structure, liquidity, valuation and risks to decide where the opportunity lies.
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Revenue Analysis
Wuxi Boton Technology's recent revenue trajectory shows quarter-over-quarter recovery juxtaposed with year-over-year contraction on a trailing twelve-month basis and across 2024. Key headline figures and contextual metrics for investors are summarized below.
- Q3 2025 revenue: 849.84 million CNY (up 16.06% vs. Q2 2025)
- Estimated Q2 2025 revenue: ~732.37 million CNY (derived from sequential growth)
- TTM revenue: 3.31 billion CNY (down 10.15% YoY)
- Annual 2024 revenue: 3.30 billion CNY (down 9.67% vs. 2023)
- 2023 revenue (implied): ~3.654 billion CNY
- Revenue per employee: ~2.19 million CNY (1,515 employees)
- Price-to-Sales (P/S) ratio: 2.84
- Market capitalization: 9.40 billion CNY; share price: 22.26 CNY (as of 2025-12-09)
| Metric | Value | Period / Note |
|---|---|---|
| Revenue (Q3) | 849.84 million CNY | Q3 2025 |
| Quarter-over-Quarter Change | +16.06% | Q3 2025 vs Q2 2025 |
| Estimated Revenue (Q2) | ~732.37 million CNY | Implied from QoQ growth |
| TTM Revenue | 3.31 billion CNY | Trailing twelve months (down 10.15% YoY) |
| Annual Revenue | 3.30 billion CNY | 2024 (down 9.67% vs 2023) |
| Revenue (2023, implied) | ~3.654 billion CNY | Derived from 2024 YoY change |
| Revenue per Employee | ~2.19 million CNY | 1,515 employees |
| Price-to-Sales (P/S) | 2.84 | Market valuation metric |
| Market Capitalization | 9.40 billion CNY | As of 2025-12-09 |
| Share Price | 22.26 CNY | As of 2025-12-09 |
For additional investor-oriented context and shareholder composition, see: Exploring Wuxi Boton Technology Co., Ltd. Investor Profile: Who's Buying and Why?
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Profitability Metrics
Wuxi Boton Technology's recent profitability profile shows modest net income and margin levels alongside a relatively high market valuation multiple. The following figures summarize the trailing twelve months (TTM) performance and key ratios that investors typically monitor.| Metric | Value |
|---|---|
| TTM Net Income | 158.95 million CNY |
| Profit Margin (TTM) | 5.55% |
| Operating Margin | 7.57% |
| Return on Assets (ROA) | 2.46% |
| Return on Equity (ROE) | 4.96% |
| Earnings Per Share (EPS, TTM) | 0.43 CNY |
| Diluted EPS (TTM) | 0.43 CNY |
| Quarterly Earnings Growth (YoY) | -36.50% |
| Trailing P/E Ratio | 57.47 |
- Profitability context: A 5.55% profit margin with a 7.57% operating margin indicates core operations retain slightly more value before non-operating items and tax.
- Capital efficiency: ROA at 2.46% and ROE at 4.96% signal modest returns on deployed assets and shareholder equity.
- Earnings trend: A YoY quarterly earnings decline of -36.50% highlights near-term pressure on profitability that investors should investigate (one-off items, demand, costs).
- Valuation signal: Trailing P/E of 57.47 implies the market is pricing future growth into current equity value despite recent earnings weakness.
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Debt vs. Equity Structure
Key capitalization and balance-sheet signals for Wuxi Boton Technology Co., Ltd. highlight an equity-dominant market valuation with modest net cash on the consolidated balance sheet and active capital return behavior.
| Metric | Value (CNY billion) | Notes |
|---|---|---|
| Market Capitalization | 9.80 | Current market equity value |
| Enterprise Value (EV) | 9.66 | EV slightly below market cap |
| Implied Net Debt (Market Cap - EV) | -0.14 | Negative net debt implies ~140 million CNY net cash |
| Price-to-Book (P/B) | 2.65 | Market values equity at 2.65x book value |
| Debt-to-Equity Ratio | Not specified | Insufficient public data to compute |
| Total A-shares Repurchased & Cancelled | 2.00 | Repurchases in CNY billion (history) |
| Controlling Shareholder Planned Reduction | Up to 2.00% | Planned July 2025 reduction by Mr. Bao Zhifang |
| 1-year Market Cap Change | +7.27% | Positive investor sentiment over 12 months |
- Net cash position: EV < market cap by 0.14 billion CNY → implies ~140 million CNY net cash available to the firm or lower net leverage.
- P/B of 2.65: market assigns a significant premium to the company's book equity - typical of growth or high-margin tech names.
- Share repurchases: 2.0 billion CNY cancelled indicates active capital return and support for EPS/book value per share.
- Shareholder liquidity event: controlling shareholder planned up-to-2% reduction (July 2025) could mildly increase free float and short-term supply pressure.
- Missing metric: Debt-to-equity ratio not provided, so direct leverage comparisons to peers require supplemental disclosure or adjusted calculations.
For corporate mission and strategic context that may influence capital structure choices, see Mission Statement, Vision, & Core Values (2026) of Wuxi Boton Technology Co., Ltd.
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Liquidity and Solvency
Recent cash flow and earnings metrics indicate improving liquidity and a stable solvency profile for Wuxi Boton Technology Co., Ltd. Key TTM figures and corporate cash distributions provide concrete context for investors assessing short-term liquidity and longer-term balance-sheet risk.
- Operating cash flow (TTM): 3.03 billion CNY - up 41.8% year-over-year, signaling stronger cash generation from core operations.
- Net income reported on cash flow statement (TTM): 158.95 million CNY.
- Depreciation & amortization (TTM): 102.55 million CNY - a non-cash expense supporting cash flow reconciliation.
- Cash dividends distributed in 2025: 4.88 billion CNY - demonstrates commitment to shareholder returns and significant cash outflow for the year.
- Solvency: No significant debt-related issues reported; overall solvency appears stable.
| Metric | TTM Value (CNY) | YoY Change / Notes |
|---|---|---|
| Operating Cash Flow | 3,030,000,000 | +41.8% YoY |
| Net Income (per cash flow statement) | 158,950,000 | TTM |
| Depreciation & Amortization | 102,550,000 | TTM |
| Cash Dividends (2025) | 4,880,000,000 | Paid in 2025 |
| Reported Debt Issues | None significant | Solvency stable |
Practical implications for investors:
- Stronger operating cash flow improves short-term liquidity and provides flexibility for capex, dividends, or debt servicing.
- Large dividend payout in 2025 (4.88 billion CNY) is material to free cash but reflects confidence in ongoing cash generation.
- Modest non-cash D&A relative to operating cash flow suggests cash-generation is not driven by one-off accounting items.
- Stable solvency and absence of major debt concerns reduce tail-risk for creditors and equity holders.
For additional investor context and shareholder composition, see: Exploring Wuxi Boton Technology Co., Ltd. Investor Profile: Who's Buying and Why?
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Valuation Analysis
Wuxi Boton Technology displays a premium market valuation driven by elevated profitability expectations and growth assumptions. Key market multiples and enterprise measures point to investor willingness to pay up for projected EPS acceleration and solid top-line expansion.- Trailing P/E: 57.47 - reflects recent earnings basis and a high current earnings multiple.
- Forward P/E: 22.46 - implies analysts expect significant earnings growth (consensus +27.8% p.a.).
- P/S: 2.84 and P/B: 2.65 - moderate valuation relative to sales and book value, above many peers in the segment.
- EV/Revenue: 3.27 and EV/EBITDA: 32.79 - indicates a premium on enterprise value vs. revenue and operating cash-profit.
- Market capitalization: 9.80 billion CNY; share price: 23.41 CNY (as of 2025-11-04).
- Analyst consensus: revenue growth ~14.9% p.a.; earnings growth ~27.8% p.a., underpinning the forward multiple compression from trailing P/E to forward P/E.
| Metric | Value | Implication |
|---|---|---|
| Share Price (2025-11-04) | 23.41 CNY | Reference market price |
| Market Cap | 9.80 billion CNY | Mid-cap status in domestic industrials/tech |
| Trailing P/E | 57.47 | High multiple on last 12 months EPS |
| Forward P/E | 22.46 | Reflects expected earnings growth |
| P/S | 2.84 | Moderate premium vs. revenue |
| P/B | 2.65 | Premium over book value |
| EV/Revenue | 3.27 | Enterprise value relative to sales |
| EV/EBITDA | 32.79 | High multiple on operating profitability |
| Analyst Revenue CAGR | 14.9% p.a. | Consensus growth expectation |
| Analyst EPS CAGR | 27.8% p.a. | Drives forward multiple improvement |
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Risk Factors
- Revenue decline: reported a year-over-year revenue decrease of 10.15%, signaling pressure on top-line growth and potential demand softness or pricing/volume challenges.
- Profitability erosion: quarterly earnings growth year-over-year is -36.50%, reflecting significant margin compression or one-off charges affecting net income.
- Shareholder pressure: the controlling shareholder's announcement to reduce holdings by up to 2.00% could weigh on investor sentiment and liquidity in secondary markets.
- Valuation concerns: trailing P/E of 57.47 is elevated versus typical industry averages, implying high investor expectations and sensitivity to earnings disappointments.
- Enterprise valuation: enterprise-to-EBITDA ratio of 32.79 indicates the company is trading at a steep multiple relative to its EBITDA, increasing downside risk if cash generation falters.
- Market-cap dynamics: market capitalization has risen 7.27% over the past year, which may draw intensified competitive scrutiny and raise expectations for sustained performance.
| Metric | Value | Implication |
|---|---|---|
| Revenue YoY change | -10.15% | Declining sales; potential structural or cyclical issues |
| Quarterly earnings growth (YoY) | -36.50% | Significant profit decline; margin pressure |
| Controlling shareholder planned reduction | Up to 2.00% | Possible negative signal to market; supply increase risk |
| Trailing P/E | 57.47 | High valuation; sensitive to earnings misses |
| Enterprise-to-EBITDA | 32.79 | Expensive relative to cash operating earnings |
| Market capitalization change (1y) | +7.27% | Moderate market value growth; may attract competition |
- Operational risk: continued revenue contraction combined with EBITDA multiple expansion heightens the need for operational improvements to justify current valuation.
- Liquidity & float risk: a controlling shareholder sell-down, even modest, can amplify volatility in a name with concentrated ownership.
- Execution risk: with profitability down substantially, management must deliver cost control, margin recovery, or new growth avenues to restore confidence.
- Market expectation risk: elevated P/E and EV/EBITDA multiples leave limited margin for error; any further earnings misses could trigger sharp rerating.
For context on corporate direction and strategic priorities, see: Mission Statement, Vision, & Core Values (2026) of Wuxi Boton Technology Co., Ltd.
Wuxi Boton Technology Co., Ltd. (300031.SZ) - Growth Opportunities
Wuxi Boton Technology sits at an inflection point where strong analyst forecasts and a supportive capital-allocation history create visible pathways for investor upside. Key forward-looking metrics point to robust earnings acceleration and sustained revenue expansion, while valuation multiples reflect market expectations for continued growth.- Analyst consensus: earnings growth of 27.8% CAGR and revenue growth of 14.9% CAGR (forward estimates).
- Share repurchase history: periodic buybacks demonstrate management focus on returning capital and improving per-share metrics.
- Market performance: market capitalization up 7.27% over the past 12 months, signaling positive investor sentiment.
- Valuation context: trailing P/E of 57.47 implies the market is pricing substantial future earnings growth.
- Enterprise-to-revenue (EV/Revenue): 3.27, consistent with expectations for top-line expansion in higher-growth technology segments.
- Current market scale: market capitalization ~9.80 billion CNY with stock price at 23.41 CNY (as of 2025-11-04).
| Metric | Value |
|---|---|
| Analyst EPS CAGR (Forecast) | 27.8% p.a. |
| Analyst Revenue CAGR (Forecast) | 14.9% p.a. |
| Trailing P/E | 57.47 |
| EV / Revenue | 3.27 |
| Market Capitalization | 9.80 billion CNY |
| Share Price (2025-11-04) | 23.41 CNY |
| 1Y Market Cap Change | +7.27% |
- Primary growth drivers: accelerating product adoption, expanded addressable market, and margin improvement from scale.
- Capital allocation strengths: buybacks that reduce share count and can amplify EPS growth if sustained.
- Valuation interpretation: premium multiples require continued execution-high EPS growth must materialize to justify current pricing.

Wuxi Boton Technology Co., Ltd. (300031.SZ) DCF Excel Template
5-Year Financial Model
40+ Charts & Metrics
DCF & Multiple Valuation
Free Email Support
Disclaimer
All information, articles, and product details provided on this website are for general informational and educational purposes only. We do not claim any ownership over, nor do we intend to infringe upon, any trademarks, copyrights, logos, brand names, or other intellectual property mentioned or depicted on this site. Such intellectual property remains the property of its respective owners, and any references here are made solely for identification or informational purposes, without implying any affiliation, endorsement, or partnership.
We make no representations or warranties, express or implied, regarding the accuracy, completeness, or suitability of any content or products presented. Nothing on this website should be construed as legal, tax, investment, financial, medical, or other professional advice. In addition, no part of this site—including articles or product references—constitutes a solicitation, recommendation, endorsement, advertisement, or offer to buy or sell any securities, franchises, or other financial instruments, particularly in jurisdictions where such activity would be unlawful.
All content is of a general nature and may not address the specific circumstances of any individual or entity. It is not a substitute for professional advice or services. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.